U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H16NO8.Na
Molecular Weight 349.2685
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Acetaminophen glucuronide sodium salt

SMILES

[Na+].CC(=O)NC1=CC=C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C([O-])=O)C=C1

InChI

InChIKey=OINXIJJEOMGKPB-CYRSAHDMSA-M
InChI=1S/C14H17NO8.Na/c1-6(16)15-7-2-4-8(5-3-7)22-14-11(19)9(17)10(18)12(23-14)13(20)21;/h2-5,9-12,14,17-19H,1H3,(H,15,16)(H,20,21);/q;+1/p-1/t9-,10-,11+,12-,14+;/m0./s1

HIDE SMILES / InChI

Molecular Formula C14H16NO8
Molecular Weight 326.2787
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Evaluating human liver reserve function by measuring serum concentrations of phenacetin and its metabolites.
2010-12
Caco-2 cell monolayers as a tool to study simultaneous phase II metabolism and metabolite efflux of indomethacin, paracetamol and 1-naphthol.
2010-01-04
The effect of transcatheter arterial chemoembolization on phase II drug metabolism enzymes in patients with hepatocellular carcinoma.
2010-01
Does rapid metabolism ensure negligible risk from bisphenol A?
2009-11
Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics.
2009-08
In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age.
2009-08
Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes.
2009-07
Simultaneous RP-HPLC determination of sotalol, metoprolol, alpha-hydroxymetoprolol, paracetamol and its glucuronide and sulfate metabolites in human urine.
2009-06
Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose.
2009-05-15
Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice.
2009-05
Simultaneous modelling of the Michaelis-Menten kinetics of paracetamol sulphation and glucuronidation.
2009-01
Effect of the acute phase response induced by endotoxin administration on the expression and activity of UGT isoforms in rats.
2008-12
Prandial insulin and the systemic appearance of meal-derived glucose in people with type 1 diabetes.
2008-11
Sources of hepatic glucose production by 2H2O ingestion and Bayesian analysis of 2H glucuronide enrichment.
2008-09
Development of an HPLC-MS/MS method for the selective determination of paracetamol metabolites in mouse urine.
2008-03-01
Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats.
2008-03
Evidence that processes other than gluconeogenesis may influence the ratio of deuterium on the fifth and third carbons of glucose: implications for the use of 2H2O to measure gluconeogenesis in humans.
2008-01
Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
2007-11
Monitoring paracetamol metabolism after single and repeated administration in pediatric patients with neoplastic diseases.
2007-09
Expression of 25 human ABC transporters in the yeast Pichia pastoris and characterization of the purified ABCC3 ATPase activity.
2007-07-10
Evidence for function of UDP galactose pyrophosphorylase in mice with absent galactose-1-phosphate uridyltransferase.
2007-06
Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life.
2007-05
Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in beta-thalassemia/HbE.
2007
Glucuronidation in the chimpanzee (Pan troglodytes): studies with acetaminophen, oestradiol and morphine.
2006-12
A pharmacokinetic study of paracetamol in Thai beta-thalassemia/HbE patients.
2006-09
Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen.
2006-08
Identification of phenacetin metabolites in human urine after administration of phenacetin-C2H3: measurement of futile metabolic deacetylation via HPLC/MS-SPE-NMR and HPLC-ToF MS.
2006-07
Ethynylestradiol increases expression and activity of rat liver MRP3.
2006-06
Comments on "shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats".
2006-02
Pathways of galactose metabolism by galactosemics: evidence for galactose conversion to hepatic UDPglucose.
2006-02
Global systems biology, personalized medicine and molecular epidemiology.
2006
Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene.
2005-11
Intra- and interindividual variability of glucuronidation of paracetamol during repeated administration of propacetamol in neonates.
2005-09
Effect of taurine on biliary excretion and metabolism of acetaminophen in male hamsters.
2004-11
Glucose production pathways by 2H and 13C NMR in patients with HIV-associated lipoatrophy.
2004-04
The quantification of paracetamol, paracetamol glucuronide and paracetamol sulphate in plasma and urine using a single high-performance liquid chromatography assay.
2004-02-18
Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans.
2003-09
Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites.
2003-09
Paracetamol and metabolite pharmacokinetics in infants.
2003-07
Transiently altered acetaminophen metabolism after liver transplantation.
2003-06
Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.
2003-06
Noninvasive evaluation of liver metabolism by 2H and 13C NMR isotopomer analysis of human urine.
2003-01-15
Analysis of acetaminophen glucuronide conjugate accompanied by adduct ion production by liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry.
2003-01-15
Feasibility of atmospheric pressure desorption/ionization on silicon mass spectrometry in analysis of drugs.
2003
Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
2002-09
Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans.
2002-08
Effect of nizatidine on paracetamol and its metabolites in human plasma.
2002-06
Acetaminophen and metabolite: lack of effect on nitric oxide synthase (constitutive or inducible).
2002-03
Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
2001-12
Intracellular inhibition of UDP-glucose dehydrogenase during ethanol oxidation.
1983-03
Substance Class Chemical
Created
by admin
on Wed Apr 02 17:11:57 GMT 2025
Edited
by admin
on Wed Apr 02 17:11:57 GMT 2025
Record UNII
2P8DNC7A3V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Acetaminophen glucuronide sodium salt
Common Name English
4-Acetamidophenyl b-D-glucuronide sodium salt
Preferred Name English
Acetaminophen-O-beta-D-glucuronide, sodium salt
Common Name English
Sodium (2S,3S,4S,5R,6S)-6-(4-acetamidophenoxy)-3,4,5-trihydroxy-tetrahydropyran-2-carboxylate
Systematic Name English
p-Acetamidophenyl ?-D-glucuronide sodium salt
Common Name English
?-D-Glucopyranosiduronic acid, 4-(acetylamino)phenyl, monosodium salt
Systematic Name English
?-D-Glucopyranosiduronic acid, 4-(acetylamino)phenyl, sodium salt (1:1)
Systematic Name English
Code System Code Type Description
PUBCHEM
23677081
Created by admin on Wed Apr 02 17:11:57 GMT 2025 , Edited by admin on Wed Apr 02 17:11:57 GMT 2025
PRIMARY
CAS
120595-80-4
Created by admin on Wed Apr 02 17:11:57 GMT 2025 , Edited by admin on Wed Apr 02 17:11:57 GMT 2025
PRIMARY
EPA CompTox
DTXSID60635519
Created by admin on Wed Apr 02 17:11:57 GMT 2025 , Edited by admin on Wed Apr 02 17:11:57 GMT 2025
PRIMARY
FDA UNII
2P8DNC7A3V
Created by admin on Wed Apr 02 17:11:57 GMT 2025 , Edited by admin on Wed Apr 02 17:11:57 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE